An experimental study to characterize the effectiveness of ferroquine against early Plasmodium falciparum blood stage infection in healthy volunteers

Trial Profile

An experimental study to characterize the effectiveness of ferroquine against early Plasmodium falciparum blood stage infection in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Ferroquine (Primary)
  • Indications Malaria
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 23 Jan 2015 Status changed from suspended to completed as reported by Australian New Zealand Clinical Trials Registry.
    • 06 Dec 2013 Status changed from recruiting to suspended as reported by Australian New Zealand Clinical Trials Registry.
    • 28 Oct 2013 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top